Insmed shares spike after FDA lifts hold

Shares of Insmed ($INSM) shot up on Friday after the company reported that the FDA has lifted a clinical hold on its trial of Arikace, an inhalable antibiotic for lung disease. Regulators had stepped in after concluding that they didn't have sufficient information to assess the risk involved in the study. Report